GRI Bio, Inc. (GRI), a biotechnology company, Tuesday announced that it has regained compliance with Nasdaq's minimum bid price rule.
The company received official notice from The Nasdaq Stock Market on March 10, confirming that it meets the requirements under Listing Rule.
GRI Bio is currently trading at $6.35, down $0.15 or 2.31 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.